Clous

Niagen Bioscience, Inc.

Nasdaq: NAGE

Medicinal Chemicals & Botanical Products · Entity-resolved by Clous

CIK0001386570
TickerNAGE
ExchangeNasdaq
SIC2833
StateDE
FY end12-31

Illustrative profile — live data lights up when a server API key is configured.

Key financials

RevenueFY2025-12-31
$129.42M
+29.9% YoY
Net IncomeFY2025-12-31
$17.38M
+103.3% YoY
Total AssetsFY2025-12-31
$106.41M
+55.8% YoY
EquityFY2025-12-31
$76.53M
+66.0% YoY
Shares OutstandingFY2025-12-31
80.08M
Operating Cash FlowFY2025-12-31
$13.5M
+11.5% YoY
ConceptFY2022-12-31FY2023-12-31FY2024-12-31FY2025-12-31YoY% rev
Revenue$72.05M$83.57M$99.6M$129.42M+29.9%100%
Net Income-$16.54M-$4.94M$8.55M$17.38M+103.3%13%
Total Assets$54.06M$54.96M$68.28M$106.41M+55.8%82%
Equity$28.67M$28.46M$46.09M$76.53M+66.0%59%
Operating Cash Flow-$15.1M$7.12M$12.11M$13.5M+11.5%10%
Shares Outstanding80.08M
Source: SEC EDGAR · resolved by Clous · as of 2026-05-30Warehouse synced 2026-06-20 06:30 UTC

Get this entity — and 970.89K+ others — programmatically.

One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.

GET /v1/entities?cik=0001386570